Insider · CIK 0001639147

Demetri George

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001639147

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2022-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	8,412
2022-03-17	Blueprint Medicines CorpS Sale	Director	SSale	−10 sh	$58.56	−$585.6	5,812
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−20K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−37.8K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−18.9K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−20K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−37.8K sh	—	—	0
2021-09-14	Translate Bio, Inc.Stock Option (right to buy)S Sale	Director	SSale	−18.9K sh	—	—	0
2021-07-13	Blueprint Medicines CorpP Purchase	Director	PPurchase	+10 sh	$82.66	+$826.6	5,822
2021-06-16	Translate Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-02	Blueprint Medicines CorpA Award	Director	AAward	+2,250 sh	—	—	5,812
2021-06-02	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,500 sh	—	—	4,500
2021-01-04	Blueprint Medicines CorpS Sale	Director	SSale	−758 sh	$112.15	−$85K	3,562
2020-09-22	Blueprint Medicines CorpS Sale	Director	SSale	−1,704 sh	$85.00	−$145K	4,320
2020-06-24	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,500 sh	—	—	4,500
2020-06-24	Blueprint Medicines CorpA Award	Director	AAward	+2,250 sh	—	—	6,024
2020-06-19	Blueprint Medicines CorpM Exercise/Conversion	Director	MExercise/Conversion	+1,312 sh	—	—	3,774
2020-06-19	Blueprint Medicines CorpRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,312 sh	—	—	0
2020-06-16	Translate Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,900
2020-01-10	Blueprint Medicines CorpS Sale	Director	SSale	−568 sh	$85.00	−$48.3K	2,462
2020-01-07	Blueprint Medicines CorpS Sale	Director	SSale	−1,705 sh	$80.59	−$137K	3,030
2019-07-12	Translate Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+37.8K sh	—	—	37,800
2019-06-19	Blueprint Medicines CorpRestricted Stock UnitsA Award	Director	AAward	+1,312 sh	—	—	1,312
2019-06-19	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,875 sh	—	—	4,875
2019-06-17	Blueprint Medicines CorpS Sale	Director	SSale	−568 sh	$100.00	−$56.8K	4,735
2019-06-17	Blueprint Medicines CorpS Sale	Director	SSale	−568 sh	$96.99	−$55.1K	5,303
2019-06-13	Blueprint Medicines CorpS Sale	Director	SSale	−568 sh	$90.00	−$51.1K	5,871
2018-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	64,771
2018-06-13	MERRIMACK PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2018-03-19	Blueprint Medicines CorpS Sale	Director	SSale	−1,200 sh	$99.06	−$119K	6,439
2018-03-19	Blueprint Medicines CorpS Sale	Director	SSale	−1,700 sh	$100.88	−$171K	10,231
2018-03-19	Blueprint Medicines CorpS Sale	Director	SSale	−2,592 sh	$100.04	−$259K	7,639
2018-02-27	Blueprint Medicines CorpS Sale	Director	SSale	−3,085 sh	$88.45	−$273K	14,696
2018-02-27	Blueprint Medicines CorpS Sale	Director	SSale	−200 sh	$90.68	−$18.1K	17,981
2018-02-27	Blueprint Medicines CorpS Sale	Director	SSale	−2,765 sh	$87.85	−$243K	11,931
2018-02-27	Blueprint Medicines CorpS Sale	Director	SSale	−200 sh	$89.48	−$17.9K	17,781
2017-12-14	MERRIMACK PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+4,890 sh	—	—	4,890
2017-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	57,271
2016-06-23	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	46,362

Recent filings

Accepted (ET)
Jun 304
Demetri George0001415889-22-007129
SEC(opens sec.gov)
Sep 144
Demetri George0001209191-21-056047
SEC(opens sec.gov)
Sep 144
Demetri George0001209191-21-056041
SEC(opens sec.gov)
Jun 164
Demetri George0001209191-21-040972
SEC(opens sec.gov)
Jun 44
Demetri George0001179110-21-006418
SEC(opens sec.gov)
Jan 64
Demetri George0001179110-21-000319
SEC(opens sec.gov)
Sep 244
Demetri George0001179110-20-009931
SEC(opens sec.gov)
Jun 264
Demetri George0001179110-20-007791
SEC(opens sec.gov)
Jun 234
Demetri George0001179110-20-007721
SEC(opens sec.gov)
Jun 164
Demetri George0001209191-20-037120
SEC(opens sec.gov)

Companies

Address

C/O BLUEPRINT MEDICINES CORPORATION, 215 FIRST STREET

CAMBRIDGE, MA, 02142